Metraipolis › archive › dc_023f09dfd055

FGD3 mediates lytic cell death, enhancing efficacy and immunogenicity of chemotherapy agents in breast cancer — Europe PMC PMID:41225536

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41225536
DOI: 10.1186/s13046-[numero omesso]-5
License (as archived): solo-consultazione
Archived: 2026-11-08T14:31:52.316Z
SHA-256 of the archived text: f933ac18663c061da4b617c69b0242a768c462efb853645572ffe5de2850c8b6
Stable URL of this page: https://metraipolis.com/documento/dc_023f09dfd055

How to cite

FGD3 mediates lytic cell death, enhancing efficacy and immunogenicity of chemotherapy agents in breast cancer — Europe PMC PMID:41225536 — Europe PMC (en), https://europepmc.org/article/MED/41225536 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_023f09dfd055 (Metraipolis archive dc_023f09dfd055, sha256 f933ac18663c061da4b617c69b0242a768c462efb853645572ffe5de2850c8b6)

BibTeX

@misc{dc023f09dfd055,
  title = {FGD3 mediates lytic cell death, enhancing efficacy and immunogenicity of chemotherapy agents in breast cancer — Europe PMC PMID:41225536},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41225536},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_023f09dfd055; sha256 f933ac18663c061da4b617c69b0242a768c462efb853645572ffe5de2850c8b6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41225536. Agents can read the archived copy with the MCP tool read_document.